A. Dondorp, F. Nosten, K. Stepniewska, N. Day, and N. White, Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial, Lancet, vol.366, pp.717-725, 2005.

A. Dondorp, C. Fanello, I. Hendriksen, E. Gomes, A. Seni et al., Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial, The Lancet, vol.376, issue.9753, pp.1647-1657, 2010.
DOI : 10.1016/S0140-6736(10)61924-1

C. Amaratunga, S. Sreng, S. Suon, E. Phelps, K. Stepniewska et al., Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study, The Lancet Infectious Diseases, vol.12, issue.11, pp.851-858, 2012.
DOI : 10.1016/S1473-3099(12)70181-0

A. Dondorp, F. Nosten, P. Yi, D. Das, A. Phyo et al., Malaria, New England Journal of Medicine, vol.361, issue.5, pp.455-467, 2009.
DOI : 10.1056/NEJMoa0808859

URL : https://hal.archives-ouvertes.fr/hal-01199794

H. Noedl, Y. Se, K. Schaecher, B. Smith, D. Socheat et al., Evidence of Artemisinin-Resistant Malaria in Western Cambodia, New England Journal of Medicine, vol.359, issue.24, pp.2619-2620, 2008.
DOI : 10.1056/NEJMc0805011

R. Rakotoarivelo, C. Razakarison, S. Gottot, R. Harintsoa, L. Randrianiriana et al., Assessment of the management of cases of fever and malaria by general practitioners in the central Highlands of Madagascar, pp.317-322, 2009.

R. Haynes, K. Cheu, H. Chan, H. Wong, K. Li et al., Interactions between Artemisinins and other Antimalarial Drugs in Relation to the Cofactor Model-A Unifying Proposal for Drug Action, ChemMedChem, vol.39, issue.12, pp.2204-2226, 2012.
DOI : 10.1002/cmdc.201200383

S. Pandey, H. Dwivedi, S. Singh, W. Siddiqui, and R. Tripathi, Antimalarial interaction of quinine and quinidine with clarithromycin, Parasitology, vol.17, issue.03, pp.406-413, 2012.
DOI : 10.1186/1475-2875-7-S1-S7

N. White, Preventing antimalarial drug resistance through combinations, Drug Resistance Updates, vol.1, issue.1, pp.3-9, 1998.
DOI : 10.1016/S1368-7646(98)80208-2

B. Pradines, M. Torrentino-madamet, A. Fontaine, M. Henry, E. Baret et al., Atorvastatin Is 10-Fold More Active In Vitro than Other Statins against Plasmodium falciparum, Antimicrobial Agents and Chemotherapy, vol.51, issue.7, pp.2654-2655, 2007.
DOI : 10.1128/AAC.01330-06

V. Parquet, S. Briolant, M. Torrentino-madamet, M. Henry, L. Almeras et al., Atorvastatin Is a Promising Partner for Antimalarial Drugs in Treatment of Plasmodium falciparum Malaria, Antimicrobial Agents and Chemotherapy, vol.53, issue.6, pp.2248-2252, 2009.
DOI : 10.1128/AAC.01462-08

N. Wurtz, S. Briolant, M. Gil, V. Parquet, M. Henry et al., Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene, Journal of Antimicrobial Chemotherapy, vol.65, issue.7, pp.1387-1394, 2010.
DOI : 10.1093/jac/dkq173

V. Parquet, M. Henry, N. Wurtz, J. Dormoi, S. Briolant et al., Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum, Malaria Journal, vol.9, issue.1, p.139, 2010.
DOI : 10.1186/1475-2875-9-139

H. Savini, J. Souraud, S. Briolant, E. Baret, R. Amalvict et al., Atorvastatin as a Potential Antimalarial Drug: In Vitro Synergy in Combinational Therapy with Dihydroartemisinin, Antimicrobial Agents and Chemotherapy, vol.54, issue.2, pp.966-967, 2010.
DOI : 10.1128/AAC.01006-09

V. Borek-dohalsky, J. Huclova, B. Barrett, B. Nemec, I. Ulc et al., Validated HPLC???MS???MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma???pharmacokinetic study, Analytical and Bioanalytical Chemistry, vol.35, issue.2, pp.275-285, 2006.
DOI : 10.1007/s00216-006-0655-3

A. Bienvenu and S. Picot, Statins Alone Are Ineffective in Cerebral Malaria but Potentiate Artesunate, Antimicrobial Agents and Chemotherapy, vol.52, issue.11, pp.4203-4204, 2008.
DOI : 10.1128/AAC.00513-08

J. Souraud, S. Briolant, J. Dormoi, J. Mosnier, H. Savini et al., Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model, Malaria Journal, vol.11, issue.1, p.13, 2012.
DOI : 10.1056/NEJMoa0808859

URL : https://hal.archives-ouvertes.fr/pasteur-00836498

J. Lou, R. Lucas, and G. Grau, Pathogenesis of Cerebral Malaria: Recent Experimental Data and Possible Applications for Humans, Clinical Microbiology Reviews, vol.14, issue.4, pp.810-820, 2001.
DOI : 10.1128/CMR.14.4.810-820.2001

N. Delahaye, N. Coltel, D. Puthier, M. Barbier, P. Benech et al., Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice, BMC Genomics, vol.8, issue.1, p.452, 2007.
DOI : 10.1186/1471-2164-8-452

P. Lackner, R. Beer, V. Heussler, G. Goebel, D. Rudzki et al., Behavioural and histopathological alterations in mice with cerebral malaria, Neuropathology and Applied Neurobiology, vol.50, issue.2, pp.177-188, 2006.
DOI : 10.1136/jnnp.69.4.433

R. Kobbe, N. Schreiber, M. J. Jacobs, and T. , Simvastatin Treatment Shows No Effect on the Incidence of Cerebral Malaria or Parasitemia during Experimental Malaria, Antimicrobial Agents and Chemotherapy, vol.52, issue.4, pp.1583-1584, 2008.
DOI : 10.1128/AAC.01428-07

A. Helmers, D. Gowda, K. Kain, and W. Liles, Statins Fail to Improve Outcome in Experimental Cerebral Malaria and Potentiate Toll-Like Receptor-Mediated Cytokine Production by Murine Macrophages, American Journal of Tropical Medicine and Hygiene, vol.81, issue.4, pp.631-637, 2009.
DOI : 10.4269/ajtmh.2009.09-0204

P. Lackner, R. Beer, R. Helbok, G. Broessner, K. Engelhardt et al., Scanning electron microscopy of the neuropathology of murine cerebral malaria, Malaria Journal, vol.5, issue.1, p.116, 2006.
DOI : 10.1186/1475-2875-5-116

V. White, S. Lewallen, N. Beare, M. Molyneux, and T. Taylor, Retinal Pathology of Pediatric Cerebral Malaria in Malawi, PLoS ONE, vol.160, issue.2, p.4317, 2009.
DOI : 10.1371/journal.pone.0004317.t002

P. Reis, V. Estato, T. Da-silva, D. Avila, J. Siqueira et al., Statins Decrease Neuroinflammation and Prevent Cognitive Impairment after Cerebral Malaria, PLoS Pathogens, vol.233, issue.12, p.1003099, 2012.
DOI : 10.1371/journal.ppat.1003099.s007

URL : http://doi.org/10.1371/journal.ppat.1003099

Y. Martins, L. Carvalho, and C. Daniel-ribeiro, Challenges in the Determination of Early Predictors of Cerebral Malaria: Lessons from the Human Disease and the Experimental Murine Models, Neuroimmunomodulation, vol.16, issue.2, pp.134-145, 2009.
DOI : 10.1159/000180268

N. Hunt and G. Grau, Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria, Trends in Immunology, vol.24, issue.9, pp.491-499, 2003.
DOI : 10.1016/S1471-4906(03)00229-1

L. Carvalho, H. Lenzi, M. Pelajo-machado, D. Oliveira, C. Daniel-ribeiro et al., Plasmodium berghei: Cerebral Malaria in CBA Mice Is Not Clearly Related to Plasma TNF Levels or Intensity of Histopathological Changes, Experimental Parasitology, vol.95, issue.1, pp.1-7, 2000.
DOI : 10.1006/expr.2000.4508

Z. Taoufiq, P. Pino, N. Dilimabaka, N. Arrouss, I. Assi et al., Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage, Malaria Journal, vol.10, issue.1, p.52, 2011.
DOI : 10.1016/j.exppara.2010.01.005

URL : https://hal.archives-ouvertes.fr/inserm-00663669

J. Greenwood, L. Steinman, and S. Zamvil, Statin therapy and autoimmune disease: from protein prenylation to immunomodulation, Nature Reviews Immunology, vol.116, issue.5, pp.358-370, 2006.
DOI : 10.1038/nri1839

J. Greenwood and J. Mason, Statins and the vascular endothelial inflammatory response, Trends in Immunology, vol.28, issue.2, pp.88-98, 2007.
DOI : 10.1016/j.it.2006.12.003

P. Newton, K. Barnes, P. Smith, A. Evans, W. Chierakul et al., The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria, European Journal of Clinical Pharmacology, vol.41, issue.Suppl 1, pp.1003-1009, 2006.
DOI : 10.1007/s00228-006-0203-2

H. Arai, T. Hiro, T. Kimura, T. Morimoto, K. Miyauchi et al., More Intensive Lipid Lowering is Associated with Regression of Coronary Atherosclerosis in Diabetic Patients with Acute Coronary Syndrome ???Sub-Analysis of JAPAN-ACS Study, Journal of Atherosclerosis and Thrombosis, vol.17, issue.10, pp.1096-1107, 2010.
DOI : 10.5551/jat.5660

S. Clauss, K. Holmes, P. Hopkins, E. Stein, M. Cho et al., Efficacy and Safety of Lovastatin Therapy in Adolescent Girls With Heterozygous Familial Hypercholesterolemia, PEDIATRICS, vol.116, issue.3, pp.682-688, 2005.
DOI : 10.1542/peds.2004-2090

S. Miura and K. Saku, Effects of statin and lipoprotein metabolism in heart failure, Journal of Cardiology, vol.55, issue.3, pp.287-290, 2010.
DOI : 10.1016/j.jjcc.2010.02.003

J. Versmissen, D. Oosterveer, M. Yazdanpanah, J. Defesche, D. Basart et al., Efficacy of statins in familial hypercholesterolaemia: a long term cohort study, BMJ, vol.337, issue.nov11 1, p.2423, 2008.
DOI : 10.1136/bmj.a2423

Y. Ohtsuka, J. Lee, D. Stamm, and I. Sanderson, MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine, Gut, vol.49, issue.4, pp.526-533, 2001.
DOI : 10.1136/gut.49.4.526

X. Yan, T. Tumpey, S. Kunkel, J. Oakes, and R. Lausch, Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1- infected cornea, Invest Ophthalmol Vis Sci, vol.39, pp.1854-1862, 1998.

S. Villeda, J. Luo, K. Mosher, B. Zou, M. Britschgi et al., The ageing systemic milieu negatively regulates neurogenesis and cognitive function, Nature, vol.169, issue.7362, pp.90-94, 2011.
DOI : 10.1038/nature10357

M. Isgro, L. Bianchetti, M. Marini, A. Bellini, M. Schmidt et al., The C-C motif chemokine ligands CCL5, CCL11, and CCL24 induce the migration of circulating fibrocytes from patients with severe asthma, Mucosal Immunology, vol.93, issue.4, pp.718-724, 2013.
DOI : 10.1111/j.1582-4934.2011.01344.x

J. Mei, Y. Liu, N. Dai, C. Hoffmann, K. Hudock et al., Cxcr2 and Cxcl5 regulate the IL-17/G-CSF axis and neutrophil homeostasis in mice, Journal of Clinical Investigation, vol.122, issue.3, pp.974-986, 2012.
DOI : 10.1172/JCI60588DS1

J. Song, C. Wu, X. Zhang, and L. Sorokin, In Vivo Processing of CXCL5 (LIX) by Matrix Metalloproteinase (MMP)-2 and MMP-9 Promotes Early Neutrophil Recruitment in IL-1??-Induced Peritonitis, The Journal of Immunology, vol.190, issue.1, pp.401-410, 2013.
DOI : 10.4049/jimmunol.1202286

S. Zhou, Z. Dai, Z. Zhou, X. Wang, G. Yang et al., Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma, Hepatology, vol.16, issue.6, pp.2242-2254, 2012.
DOI : 10.1002/hep.25907

C. Clark and R. Phillips, Cerebral malaria protection in mice by species-specific Plasmodium coinfection is associated with reduced CC chemokine levels in the brain, Parasite Immunology, vol.36, issue.11, pp.637-641, 2011.
DOI : 10.1111/j.1365-3024.2011.01329.x

M. Steigerwald and H. Moll, Leishmania major Modulates Chemokine and Chemokine Receptor Expression by Dendritic Cells and Affects Their Migratory Capacity, Infection and Immunity, vol.73, issue.4, pp.2564-2567, 2005.
DOI : 10.1128/IAI.73.4.2564-2567.2005

R. Basir, S. Rahiman, K. Hasballah, W. Chong, H. Talib et al., Plasmodium berghei ANKA infection in ICR mice as a model of cerebral malaria, Iran J Parasitol, vol.7, pp.62-74, 2012.

A. Villegas-mendez, R. Greig, T. Shaw, J. De-souza, G. Findlay et al., IFN-??-Producing CD4+ T Cells Promote Experimental Cerebral Malaria by Modulating CD8+ T Cell Accumulation within the Brain, The Journal of Immunology, vol.189, issue.2, pp.968-979, 2012.
DOI : 10.4049/jimmunol.1200688

A. Niessner, S. Steiner, W. Speidl, J. Pleiner, D. Seidinger et al., Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo, Atherosclerosis, vol.189, issue.2, pp.408-413, 2006.
DOI : 10.1016/j.atherosclerosis.2005.12.022

M. Terblanche, Y. Almog, R. Rosenson, T. Smith, and D. Hackam, Statins and sepsis: multiple modifications at multiple levels, The Lancet Infectious Diseases, vol.7, issue.5, pp.358-368, 2007.
DOI : 10.1016/S1473-3099(07)70111-1

N. Wilson, V. Jain, C. Roberts, N. Lucchi, P. Joel et al., CXCL4 and CXCL10 Predict Risk of Fatal Cerebral Malaria, Disease Markers, vol.30, issue.1, pp.439-488, 2011.
DOI : 10.1155/2011/828256

B. Sarfo, N. Wilson, V. Bond, and J. Stiles, Plasmodium berghei ANKA infection increases Foxp3, IL-10 and IL-2 in CXCL-10 deficient C57BL/6 mice, Malaria Journal, vol.10, issue.1, p.69, 2011.
DOI : 10.1158/1078-0432.CCR-06-1417

J. Kurtzhals, V. Adabayeri, B. Goka, B. Akanmori, J. Oliver-commey et al., Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria, The Lancet, vol.351, issue.9118, pp.1768-1772, 1998.
DOI : 10.1016/S0140-6736(97)09439-7

P. Hanum, M. Hayano, and S. Kojima, Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain, International Immunology, vol.15, issue.5, pp.633-640, 2003.
DOI : 10.1093/intimm/dxg065

Y. Martins, G. Werneck, L. Carvalho, B. Silva, B. Andrade et al., Algorithms to predict cerebral malaria in murine models using the SHIRPA protocol, Malaria Journal, vol.9, issue.1, p.85, 2010.
DOI : 10.1186/1475-2875-9-85

A. Trampuz, M. Jereb, I. Muzlovic, and R. Prabhu, Clinical review: severe malaria, Critical Care, vol.7, issue.4, pp.315-323, 2003.
DOI : 10.1186/cc2183

J. Carter, V. Mung-'ala-odera, B. Neville, G. Murira, N. Mturi et al., Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children, Journal of Neurology, Neurosurgery & Psychiatry, vol.76, issue.4, pp.476-481, 2005.
DOI : 10.1136/jnnp.2004.043893

M. Boivin, P. Bangirana, J. Byarugaba, R. Opoka, R. Idro et al., Cognitive Impairment After Cerebral Malaria in Children: A Prospective Study, PEDIATRICS, vol.119, issue.2, pp.360-366, 2007.
DOI : 10.1542/peds.2006-2027